Protease-activated Receptor-1 Antagonists

*Prices reflect U.S. average retail price

Zontivity (vorapaxar)

VORAPAXAR helps to prevent blood clots. It is used in patients with a previous heart attack or blockages in the arteries of the legs to reduce the risk of heart attack, stroke, or the need for procedures to restore blood flow to the heart.

 

 

Manufacturer's Website: Zontivity                                                                                                                     Average retail cost: $516/month

 

Copyright  2006---2023  Automated Clinical Guidelines, LLC.  All rights reserved.